편집
13,127
번
새 문서: {{논문 |1=Efficacy, durability, and safety of intravitreal faricimab up to every 16w for nAMD (TENAYA and LUCERNE) : 2 randomised, double-masked, P3, non-inferiority trials<ref>Heie...
(새 문서: {{논문 |1=Efficacy, durability, and safety of intravitreal faricimab up to every 16w for nAMD (TENAYA and LUCERNE) : 2 randomised, double-masked, P3, non-inferiority trials<ref>Heie...) |
(차이 없음)
|